The Ann Romney Center for Neurologic Diseases will soon move to the Brigham Building for the Future.

Today, more than 50 million people worldwide suffer from complex neurologic diseases. In recent years, however, researchers have made significant advances in their understanding of these conditions. To leverage this progress, Brigham and Women’s Hospital (BWH) has developed the Ann Romney Center for Neurologic Diseases. Led by Co-Directors Howard L. Weiner, MD, and Dennis J. Selkoe, MD, the Center is a collaborative, global effort designed to accelerate treatment, prevention, and cures for five of the world’s most complex neurologic diseases – multiple sclerosis (MS), Alzheimer’s disease, ALS (Lou Gehrig’s disease), Parkinson’s disease, and brain tumors.

Launched in October 2014, the Center will soon move to the Brigham Building for the Future, opening in 2016. This new facility will feature a medical ecosystem where world-renowned scientists and physicians will pursue life-changing cures for neurologic diseases. Along with a unique design that fosters collaboration and accelerated discovery, the center will be one of the most technologically sophisticated patient care and research facilities in the country – a place where scientists and physicians come together to share medical advances in the fields of genetics, cell biology, musculoskeletal disease, inflammatory disease, neurosurgery, neuropathology, and biochemistry.

Watch our video to learn more about why the Ann Romney Center, which builds on 30 years of remarkable science under the direction of Drs. Weiner and Selkoe, offers enduring hope for patients and families who confront neurologic diseases. To set up an appointment with one of our neurologists, please call us toll-free at 1-855-278-8009 Monday-Friday, 8am–5pm, Eastern Time.

comments (0)